Pro Medicus Ltd./ADR Business Summary

Pro Medicus Ltd. (PMDIY) operates a high-margin, software-only business model primarily generating revenue through long-term, transaction-based licensing fees for its Visage 7 enterprise imaging platform. The company’s revenue streams are diversified across three core segments: Enterprise Imaging (viewing, archive, and workflow), Radiology Information Systems (RIS), and emerging clinical domains including Cardiology and Digital Pathology. Pro Medicus utilizes a cloud-native, "pay-per-transaction" subscription model that scales with clinical volume, complemented by professional service fees for implementation and training. In the competitive landscape, the company competes directly with Sectra, GE HealthCare, and Philips. Pro Medicus distinguishes itself as the premium, high-performance market leader, specifically targeting top-tier academic medical centers and large Integrated Delivery Networks (IDNs) that require rapid, server-side rendering of massive medical datasets. The company is led by its original founding team, providing exceptional management stability and alignment. Co-founder and CEO Dr. Sam Hupert, a former medical practitioner with an M.B.B.S. from Monash University, provides clinical and strategic oversight, while Co-founder and Technology Director Anthony Hall, a La Trobe University alumnus, serves as the principal architect of the core software. The technical leadership is further bolstered by Global CTO Dr. Malte Westerhoff, a PhD in computer science and mathematics who was instrumental in the development of the Visage technology. The board is chaired by Peter Terence Kempen, a former Managing Partner at Ernst & Young Corporate Finance. Pro Medicus maintains a unique ownership structure where the two founders retain a combined stake of approximately 46% as of March 2026, supported by significant institutional backing from The Vanguard Group and BlackRock.